Overview

A 10-gene NGS test reframes lung risk from smoking history alone to a genetic signal, helping clinics flag higher-risk patients earlier. The population angle is prevention: a compact panel suits screening and counseling rather than late-stage treatment selection. By adding a heritable layer to the risk picture, programs can prioritize who receives imaging and closer follow-up without testing everyone. Programs that adopt the panel typically pair it with a counseling visit, so a higher-risk result leads directly to a surveillance plan rather than anxiety.

How It Works

Ten curated genes linked to lung carcinogenesis are captured and sequenced from a saliva or blood sample. Variants are classified by cancer-risk tier, and the report returns a per-gene risk statement with counseling notes. The small gene set keeps cost and turnaround friendly for high-volume screening programs. Automated classification rules apply the same tier definitions to every sample, so results are consistent across a large cohort.

Clinical Indications

It fits individuals with family history or occupational exposure who want a structured risk read, and wellness programs that bundle genetic counseling. It is not a diagnostic test for active cancer but a population-selection tool. Clinics use it to decide which patients enter low-dose CT surveillance earlier than guideline age cutoffs would suggest. Some occupational-health schemes also use the tier to set the frequency of low-dose CT, shortening the interval for the highest band.

Specimen & Turnaround

A saliva kit or 5 mL blood tube is accepted. Reporting returns tiered risk with a counseling summary; inconclusive findings are flagged rather than forced. Results are released with a plain-language explainer so the patient understands the difference between risk and diagnosis.

Storage & Logistics

Saliva and blood kits ship ambient with stabilizers; the service lab supplies pre-labelled collection so distributors can run population programs without cold chain. Batch shipment and centralized reading keep per-test cost low enough for routine, large-scale screening deployments. Centralized reading avoids the variability of many small local labs interpreting risk tiers differently, which matters when results are compared across a cohort.

FAQ

Q: Who should take a 10-gene lung risk test? A: Those with family history or exposure who want a structured, genetic risk read. It helps clinics decide who merits earlier imaging surveillance.

Q: Is this a cancer diagnostic? A: No, it is a risk-screening tool paired with counseling, not a test for active disease. A positive result means higher risk, not current cancer.

Q: What sample works for population screening? A: A saliva or blood kit, both ambient-shippable with stabilizers. Saliva is often preferred for non-clinical wellness settings because it is easy to collect.